Skip to main content

Table 2 Tolerability of a ramped, moderate-to-vigorous intensity, exercise prescription with weekly tele-coaching

From: Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients

  Exercise time (min/wk) Average HR during exercise (bpm) Average HR prescribed (bpm) Exercise time at Rx HR (%)
Introduction phase 64.2 ± 6.8 134.2 ± 9.5 122.7 ± 13.3 72.7 ± 11.5
Intermediate phase 67.1 ± 5.7 139.3 ± 3.5 141.9 ± 12.3 61.0 ± 5.0
Maintenance phase 66.0 ± 10.4 137.8 ± 7.3 149.0 ± 11.5 23.7 ± 7.1
  1. Mean ± SEM for patients that progressed at least 2 weeks into the introduction phase (n = 6)